Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the
treatment and prophylaxis of influenza caused by influenza A and B viruses.
Learn about the prescription medication Relenza (Zanamivir), drug uses, dosage,
side effects, drug interactions, warnings, reviews and patient labeling.
Jul 1, 2010 ... Zanamivir is used in adults and children at least 7 years of age to treat some
types of influenza ('flu') in people who have had symptoms of the ...
Easy to read patient leaflet for zanamivir. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Feb 22, 2016 ... This page provides guidance specific to the use of investigational use of
intravenous zanamivir, but not for the use of FDA-approved ...
Zanamivir is an orally inhaled powder currently approved in 19 countries for the
treatment of, and in two for the prophylaxis of influenza A and B. Zanamivir is a ...
RELENZA (zanamivir) Inhalation Powder, for oral inhalation. Initial U.S. Approval:
.... (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated.
Dec 17, 2013 ... Relenza inhalation powder contains the active ingredient zanamivir, which is a
type of medicine called a neuraminidase inhibitor. It is used to ...
Medscape - Indication-specific dosing for Relenza (zanamivir), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Dec 16, 2015 ... Relenza (zanamivir) is approved for treatment of acute uncomplicated illness due
to influenza A and B in patients 7 years of age and older.